NON-SEGMENTAL VITILIGO (NSV)
Clinical trials for NON-SEGMENTAL VITILIGO (NSV) explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO (NSV) trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO (NSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to recolor skin in vitiligo patients
Disease control Recruiting nowThis study tests a new drug called LY4005130 in 60 adults with non-segmental vitiligo, a condition causing white patches on the skin. Participants receive either the drug or a placebo by IV over 24 weeks. The goal is to see if the drug safely reduces facial and body patches bette…
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
Global study to measure daily toll of hair, skin, and sweat gland diseases
Knowledge-focused Recruiting nowThis study looks at how alopecia areata, vitiligo, and hidradenitis suppurativa affect the daily lives of teens and adults. Researchers will survey nearly 2,800 people worldwide to measure symptoms, hair loss, skin changes, and quality of life. The goal is to better understand th…
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC